News Chart Arrowhead Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
63.84 ^USD	-3.64%		-1.12%	-3.84%

01-13	Aligos Therapeutics, Inc. Appoints James Hassard as Executive Vice President and Chief Commercial Officer, Effective January 13, 2026	CI
01-12	Arrowhead Pharmaceuticals issues $700 million of 0.00% convertible notes due 2032 - SEC filing	RE

a6463.RPI_i_gjEHdsPMfcyAaZmLGMG0b1ygkTqR5A2dPZoSs.drVFzMESXQ85Vb2prjfVq-jAQxSNj1Bn9ns2kJKy_kozkXq9j2tUEhVJig~c682567b0c0bfc27cf5c0868657f713b